Opko Health OPK Cash & Equivalents
Discontinued — last reported Q2 '24
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Opko Health’s 10-Q, filed August 7, 2024, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opko Health's cash & equivalents?
- Opko Health (OPK) reported cash & equivalents of $40.58M in Q2 2024.
- How has Opko Health's cash & equivalents changed year-over-year?
- Opko Health's cash & equivalents decreased by 62.5% year-over-year, from $108.11M to $40.58M.
- What is the long-term trend for Opko Health's cash & equivalents?
- Over 3 years (2020 to 2023), Opko Health's cash & equivalents has grown at a 9.9% compound annual growth rate (CAGR), from $72.21M to $95.88M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.